Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Gleeson

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Pharmaceutical Medicine|July 14, 2024
Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USAVictor L Van de Wiele, Aaron S Kesselheim, Deborah Gleeson, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2014
Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership AgreementAnne Marie Thow, Wendy Snowdon, Ronald Labonté, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Pharmaceutical Medicine|July 14, 2024
Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USAVictor L Van de Wiele, Aaron S Kesselheim, Deborah Gleeson, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2014
Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership AgreementAnne Marie Thow, Wendy Snowdon, Ronald Labonté, et al.
Pageof 8